Advancing Cancer Diagnosis: Integrating Molecular Pathology into Histopathology for Solid Tumors
A special issue of Journal of Molecular Pathology (ISSN 2673-5261).
Deadline for manuscript submissions: 31 October 2025 | Viewed by 130
Special Issue Editor
Interests: neuropathology; surgical pathology; uveal melanoma; immunohistochemistry; dermatopathology; oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The integration of molecular pathology with histopathology is transforming the diagnosis of solid tumors, enhancing precision and paving the way for personalized treatment strategies. Molecular techniques like Next-Generation Sequencing (NGS) allow comprehensive profiling of genetic alterations, while immunohistochemistry (IHC) and multiplex immunofluorescence reveal biomarker expressions essential for therapy selection. Digital pathology and AI offer improved accuracy and efficiency in tissue analysis, while liquid biopsies enable non-invasive monitoring of tumor dynamics. This multidisciplinary approach provides a deeper understanding of tumor biology, enabling tailored interventions for improved patient outcomes.
Dr. Giuseppe Broggi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Molecular Pathology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular pathology
- solid tumors
- next-generation technologies
- target treatment
- digital pathology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
